Mapping the human genetic architecture of COVID-19: an update

COVID-19 Host Genetics Initiative, Andrea Ganna
doi: https://doi.org/10.1101/2021.11.08.21265944

Abstract

The Coronavirus Disease 2019 (COVID-19) pandemic continues to pose a major public health threat especially in countries with low vaccination rates. To better understand the biological underpinnings of SARS-CoV-2 infection and COVID-19 severity we formed the COVID19 Host Genetics Initiative. Here we present GWAS meta-analysis of up to 125,584 cases and over 2.5 million controls across 60 studies from 25 countries, adding 11 new genome-wide significant loci compared to those previously identified. Genes in novel loci include SFTPD, MUC5B and ACE2, reveal compelling insights regarding disease susceptibility and severity.

Main text

The Coronavirus Disease 2019 (COVID-19) pandemic continues to pose a major public health threat especially in countries with low vaccination rates. To better understand the biological underpinnings of SARS-CoV-2 infection and COVID-19 severity we formed the COVID19 Host Genetics Initiative. Here we present GWAS meta-analysis of up to 125,584 cases and over 2.5 million controls across 60 studies from 25 countries, adding 11 new genome-wide significant loci compared to those previously identified1. Genes in novel loci include SFTPD, MUC5B and ACE2, reveal compelling insights regarding disease susceptibility and severity.

Additional genomic regions identified for COVID-19 severity and SARS-CoV-2 infection

Here we present meta-analyses bringing together 60 studies from 25 countries (Figure 1; Supplementary Table 1) for three COVID-19 related phenotypes: (1) individuals critically ill with COVID-19 based on either requiring respiratory support in hospital or who died as a consequence of the disease (9,376 cases - of which 3,197 new in this data release – and 1,776,645 controls), (2) cases with moderate or severe COVID-19 defined as those hospitalized due to symptoms associated with the infection (25,027 cases – 11,386 new - and 2,836,272 controls), and (3) all cases with reported SARS-CoV-2 infection regardless of symptoms (125,584 cases – 76,022 new - and 2,575,347 controls). An overview of the study design is provided in Supplementary Figure 1. We found a total of 23 genome-wide significant loci (P < 5 × 10−8) of which 20 loci remain significant after multiple testing corrections (P < 1.67 × 10−8) to account for the number of phenotypes examined (Figure 2; Supplementary Figure 2; Supplementary Table 2). We compared the effects of these loci between the previous1 and the current analysis and found that only one locus did not replicate (rs72711165). All the other loci showed the expected increase in statistical significance (Supplementary Figure 3).

Figure 1
Figure 1

Panel A: Geographical overview of the contributing studies to the COVID-19 HGI and composition by major ancestry groups. Populations are defined as Middle Eastern (MID), South Asian (SAS), East Asian (EAS), African (AFR), Admixed American (AMR), European (EUR). Panel B. Principal components analysis highlights the population structure and the sample ancestry of the individuals participating to the COVID-19 HGI. This figure is an updated version of the figure published by the COVID-19 Host Genetics Initiative 1.

Figure 2
Figure 2 Genome-wide association results for COVID-19.

A. Top panel shows results of genome-wide association study of hospitalized COVID-19 (n=25,027 cases and n=2,836,272 controls), and bottom panel the results of reported SARS-CoV-2 infection (n=125,584 cases and n=2,575,347 controls). Loci highlighted in yellow (top panel) represent regions associated with severity of COVID-19 manifestation. Loci highlighted in green (bottom panel) are regions associated with susceptibility to SARS-CoV-2 infection. Lead variants for the loci newly identified in this data release are annotated with their respective rsID. B. Results of gene prioritization using different evidence measures of gene annotation. Genes in linkage disequilibrium (LD) region, genes with coding variants and eGenes (fine-mapped cis-eQTL variant PIP > 0.1 in GTEx Lung) are annotated if in LD with a COVID-19 lead variant (r2 > 0.6). V2G: Highest gene prioritized by OpenTargetGenetics’ V2G score. The * indicates SARS-CoV-2 infection susceptibility and + indicates COVID-19 severity. The transparent loci were reported in the previous freeze (data release 5), and loci in bright blue were identified in the current freeze (data release 6). This figure is an updated version of the figure published by the COVID-19 Host Genetics Initiative 1.

Heterogeneity in genetic effects across phenotypes, studies, and ancestry groups

Across the genome-wide significant loci, we observed clear patterns of association to the different phenotypes under study. Thus, we developed a two-class Bayesian model for classifying loci based on the patterns of association across the two better-powered phenotypes (COVID-19 hospitalization and SARS-CoV-2 reported infection). Intuitively, loci that are associated to susceptibility will also be associated to severity as to develop COVID-19, SARS-CoV-2 infection needs to first occur. In contrast, those genetic effects that solely modify the course of illness should be associated to severity to illness and not show any association to reported infection except via preferential ascertainment of hospitalized cases in a cohort (Supplementary Methods). We identified 16 loci that are substantially more likely (> 99% posterior probability) to impact the risk of COVID-19 hospitalization and 7 loci that clearly influence susceptibility to SARS-CoV-2 infection (Supplementary Table 3; Supplementary Figure 4).

We observed that several loci had a significant heterogeneous effect across studies (6/23 loci with P-value for heterogeneity < 2.2×10−3; Supplementary Table 2). Thanks to an increased diversity in our study population (Supplementary Figure 5) we were able to explore if such heterogeneity was due to effect differences across continental ancestry groups. Only one locus (FOXP4) showed a significantly different effect across ancestries (P-value heterogeneity < 7×10−5; Supplementary Table 4 and Supplementary Figure 6), though even at this locus all ancestry groups showed a positive effect estimate. This confirms that factors related to between-study heterogeneity (e.g., variable definition of COVID-19 severity due to different thresholds for testing, hospitalization, and patient recruitment) rather than differences across ancestries are a more likely explanation for the observed heterogeneity in the effect sizes across studies.

Biological insights from novel loci

For the 23 genome-wide significant loci, we explored candidate causal genes and performed a phenome-wide association study to better understand their potential biological mechanisms (Supplementary Table 2,5,6; Supplementary Figure 7). Several of these loci with prior and direct connections to lung disease and SARS-CoV-2 infection mechanism are highlighted here.

Several loci involved in COVID-19 severity implicate lung surfactant biology. A missense variant rs721917:A>G (p.Met31Thr) in SFTPD (10q22.3) confers risk for hospitalization (OR [95% confidence interval [CI] = 1.06 [1.04, 1.08]; P = 1.7 × 10−8) and has been previously associated with increased risk of chronic obstructive pulmonary disease2 (OR = 1.08; P = 2.0 × 10−8), and decreased lung function3 (FEV1/FVC; β = –0.019; P = 2.0 × 10−15). SFTPD encodes the surfactant protein D (SP-D) that participates in innate immune response, protecting the lungs against inhaled microorganisms. The recombinant fragment of SP-D binds to the S1 spike protein of the SARS-CoV-2 and potentially inhibits binding to ACE2 receptor and SARS-CoV-2 infection4. Another missense variant rs117169628:G>A (p.Pro256Leu) in SLC22A31 (16q24.3) also conferring risk for hospitalization (OR [95% CI] = 1.09 [1.06, 1.13]; P = 2.6 × 10−8). SLC22A31 belongs to the family of solute carrier proteins that facilitate transport across membranes5 and is co-regulated with other surfactant proteins6.

We found a variant rs35705950:G>T located in the promoter of MUC5B (11p15.5) to be protective against hospitalization (OR [95% CI] = 0.83 [0.86, 0.93]; P = 6.5 × 10−9). This well-studied promoter variant increases expression of MUC5B in lung in GTEx (P = 6.7 × 10−16) and is the strongest known variant associated with increased risk of developing idiopathic pulmonary fibrosis (IPF)7,8, but also improves survival in IPF patients carrying this mutation9.

Finally, we identified rs190509934:T>C, located 69 bp upstream of ACE2 (Xp22.2) to be associated with decreased susceptibility risk (OR [95% CI] = 0.69 [0.63, 0.75]; P = 3.6 × 10−18). ACE2 is the SARS-CoV-2 receptor and functionally interacts with SLC6A19 and SLC6A20 10, one of which also showed a significant association with susceptibility (rs73062389:G>A at SLC6A20; OR [95% CI] = 1.18 [1.16, 1.20]; P = 2.5 × 10−74). Notably, rs190509934 is 10 times more common in South Asians (MAF = 0.027) than in Europeans (MAF = 0.0024), demonstrating the importance of diversity for variant discovery. Recent results have shown that rs190509934:T>C variant lowers ACE2 expression, which in turn confers protection from SARS-CoV-2 infection11.

We applied Mendelian randomization to infer potential causal relationships between COVID-19 related phenotypes and their genetically correlated traits (Supplementary Methods; Supplementary Tables 7,8,9; Supplementary Figure 8). A novel causal association was observed between genetic liability to type II diabetes (T2D) and SARS-CoV-2 reported infection (OR [95% CI] = 1.02 [1.01, 1.03]; P = 1.6 × 10-3), and COVID-19 hospitalization (OR [95% CI] = 1.06 [1.03, 1.1]; P = 1.4 × 10-4). Multivariable MR (MVMR) was used to estimate the direct effect of liability to T2D on COVID-19-related phenotypes that was not mediated via BMI. This analysis indicated that the observed causal association of liability to T2D on COVID-19 phenotypes is mediated by BMI (Supplementary Table 10).

Discussion

We have substantially expanded the genetic analysis of SARS-CoV-2 infection and COVID-19 severity by doubling the case size, identifying 11 novel loci. We developed a new approach to systematically assign the 23 discovered loci to either disease susceptibility (7 loci) or disease severity (16 loci). While distinguishing the two phenotypes is challenging because progression to a severe form of the disease requires susceptibility to infection in the first place, it is now evident that the genetic mechanisms involved in these two aspects of the disease can be differentiated. Among the new loci associated with disease susceptibility, ACE2 represents an expected, yet interesting finding. MUC5B, SFTPD, and SLC22A31 are the three most interesting novel loci associated with COVID-19 severity. Their relationship with lung function and lung diseases is consistent with loci previously associated with disease severity. The SPs secreted by alveolar cells, representing an emerging biological mechanism, maintains healthy lung function and facilitates the clearance of pathogens12. The protective effect of the MUC5B variant is unexpected given the otherwise risk-increasing, concordant effect between IPF and COVID-19 observed for other variants8. Nonetheless, this result aligns with the MUC5B promoter variant association that shows a twofold higher survival rate among IPF patients 9. In mice, Muc5b appears essential for effective mucociliary clearance and for controlling infection13 supporting therapies to control mucin secretion to be of potential benefit in COVID-19 patients.

Expanding genomic research to include participants from around the world enabled us to test if the effect of COVID-19related genetic variants was markedly different across ancestry groups. We didn’t detect obvious heterogeneity between ancestry groups, and we attribute the observed heterogeneity in the effect of COVID-19 related genetic variants to the diverse inclusion criteria across studies in terms of COVID-19 severity. However, we also note that ascertainment differences across studies might mask true underlying differences in effect sizes between ancestry groups.

The novel biological insights gained by this expansion of the COVID-19 Host Genetic Initiative showed that increasing sample size and diversity remain a fruitful activity to better understand the human genetic architecture of COVID-19.

Data Availability

All data produced are available online at https://www.covid19hg.org

https://www.covid19hg.org

Data Availability

Summary statistics generated by COVID-19 HGI are available at https://www.covid19hg.org/results/r6/. The analyses described here utilize the freeze 6 data. COVID-19 HGI continues to regularly release new data freezes. Summary statistics for non-European ancestry samples are not currently available due to the small individual sample sizes of these groups, but results for 23 loci lead variants are reported in Supplementary Table 3. Individual level data can be requested directly from contributing studies, listed in Supplementary Table 1. We used publicly available data from GTEx (https://gtexportal.org/home/), the Neale lab (http://www.nealelab.is/uk-biobank/), Finucane lab (https://www.finucanelab.org), FinnGen Freeze 4 cohort (https://www.finngen.fi/en/access_results), and eQTL catalogue release 3 (http://www.ebi.ac.uk/eqtl/).

Code Availability

The code for summary statistics lift-over, the projection PCA pipeline including precomputed loadings and meta-analyses are available on GitHub (https://github.com/covid19-hg/) and the code for the Mendelian randomization and genetic correlation pipeline is available on GitHub at https://github.com/marcoralab/MRcovid. Code for implementing the MVMR analysis is available at: https://github.com/marcoralab/multivariate_MR; and subtype analyses at: https://github.com/mjpirinen/covid19-hgi_subtypes

Competing Interests

A full list of competing interests is supplied as Supplementary Table 11.

Author contributions

Detailed author contributions are integrated in the authorship list.

COVID-19 Host Genetics Initiative

Leadership

Leadership

Gita A. Pathak1,

Juha Karjalainen2,

Christine Stevens3,

Benjamin M Neale4,

Mark Daly2,3,5,

Andrea Ganna2,3,5

Writing group

Writing group lead

Gita A. Pathak1,

Shea J. Andrews6,

Masahiro Kanai3,

Mattia Cordioli7,

Andrea Ganna2,3,5

Analysis group

Manuscript analyses team lead

Juha Karjalainen2

Manuscript analyses team members: phewas

Gita A. Pathak1,

Renato Polimanti1

Manuscript analyses team members: mendelian randomization

Shea J. Andrews6,

Nadia Harerimana8

Manuscript analyses team members: methods development

Mattia Cordioli7,

Matti Pirinen7

Manuscript analyses team members: PC projection, gene prioritization

Masahiro Kanai3

Project management group

Project management lead

Christine Stevens3,

Rachel G. Liao3

Project managment support

Karolina Chwialkowska9,

Amy Trankiem3,

Mary K. Balaconis3

Website development

Website development

Huy Nguyen3,

Matthew Solomonson3

Scientific communication group

Scientific communication lead

Kumar Veerapen3,

Brooke Wolford10

AncestryDNA COVID-19 Research Study

Analysis Team Lead

Genevieve Roberts11

Data Collection Lead

Danny Park11

Admin Team Lead

Catherine A. Ball11

Analysis Team Member

Marie Coignet11,

Shannon McCurdy11,

Spencer Knight11,

Raghavendran Partha11,

Brooke Rhead11

Data Collection Member

Miao Zhang11,

Nathan Berkowitz11,

Michael Gaddis11,

Keith Noto11,

Luong Ruiz11,

Milos Pavlovic11

Admin Team Member

Eurie L. Hong11,

Kristin Rand11,

Ahna Girshick11,

Harendra Guturu11,

Asher Haug Baltzell11

BelCovid

Analysis Team Lead

Mari E.K. Niemi12

Data Collection Lead

Souad Rahmouni13,

Julien Guntz14

Admin Team Lead

Yves Beguin15

Analysis Team Member

Mattia Cordioli16,

Sara Pigazzini12,

Lindokuhle Nkambule17,18,19

Data Collection Member

Michel Georges13,

Michel Moutschen20,21,

Benoit Misset20,21,

Gilles Darcis20,21,

Julien Guiot20,21,

Samira Azarzar20,21,

Stéphanie Gofflot15,

Sabine Claassen14,

Olivier Malaise20,

Pascale Huynen20,

Christelle Meuris22,

Marie Thys22,

Jessica Jacques22,

Philippe Léonard22,

Frederic Frippiat22,

Jean-Baptiste Giot22,

Anne-Sophie Sauvage22,

Christian Von Frenckell22,

Yasmine Belhaj13,

Bernard Lambermont22

Biobanque Quebec COVID19

Analysis Team Lead

Tomoko Nakanishi23,24,25,26

Data Collection Lead

David R. Morrison24

Admin Team Lead

Vincent Mooser27,

J. Brent Richards24,28,29

Analysis Team Member

Guillaume Butler-Laporte24,30,

Vincenzo Forgetta24,

Rui Li27

Data Collection Member

Biswarup Ghosh24,

Laetitia Laurent24,

Alexandre Belisle27,

Danielle Henry24,

Tala Abdullah24,

Olumide Adeleye24,

Noor Mamlouk24,

Nofar Kimchi24,

Zaman Afrasiabi24,

Nardin Rezk24,

Branka Vulesevic24,

Meriem Bouab24,

Charlotte Guzman24,

Louis Petitjean24,

Chris Tselios24,

Xiaoqing Xue24,

Jonathan Afilalo24,

Marc Afilalo31,32,

Maureen Oliveira33,

Bluma Brenner34,

Nathalie Brassard35,

Madeleine Durand36,37

Admin Team Member

Erwin Schurr38,

Pierre Lepage27,

Jiannis Ragoussis27,

Daniel Auld27,

Michaël Chassé37,39,

Daniel E. Kaufmann37,40,

G. Mark Lathrop27,

Darin Adra24

CCHC COVID-19 GAWS

Analysis Team Lead

Caroline Hayward41,

Joseph T Glessner42,43,

Douglas M Shaw44

Data Collection Lead

Archie Campbell45,

Marcela Morris46

Admin Team Lead

Hakon Hakonarson42,43,

David J Porteous47,

Jennifer Below44

Analysis Team Member

Anne Richmond41,

Xiao Chang42,

Hannah Polikowski44,

Petty E Lauren44,

Hung-Hsin Chen44,

Zhu Wanying44

Data Collection Member

Chloe Fawns-Ritchie48

Admin Team Member

Kari North49,

Joseph B McCormick46

CHOP_CAG

Data Collection Member

Xiao Chang50,

Joseph R Glessner51,52,

Hakon Hakonarson51,53,54

Colorado Center for Personalized Medicine (CCPM)

Analysis Team Lead

Christopher R Gignoux55

Data Collection Lead

Stephen J Wicks55,

Kristy Crooks55

Admin Team Lead

Kathleen C Barnes55

Analysis Team Member

Michelle Daya55,

Jonathan Shortt55,

Nicholas Rafaels55,

Sameer Chavan55

Coronagenes

Analysis Team Lead

Paul RHJ Timmers56,57,

James F Wilson56,57,

Albert Tenesa56,58

Admin Team Lead

Shona M Kerr56

Analysis Team Member

Kenton D’Mellow58

Egypt hgCOVID hub

Analysis Team Lead

Mari E.K. Niemi12

Data Collection Lead

Doaa Shahin59,

Yasser M. El-Sherbiny59,60

Admin Team Lead

Kathrin Aprile von Hohenstaufen61,

Ali Sobh62,

Madonna M. Eltoukhy63

Analysis Team Member

Mattia Cordioli7,

Lindokuhle Nkambul17,64

Data Collection Member

Tamer A. Elhadidy65,

Mohamed S. Abd Elghafar66,

Jehan J. El-Jawhari59,60,

Attia A.S. Mohamed63,

Marwa H. Elnagdy67,

Amr Samir68,

Mahmoud Abdel-Aziz69,

Walid T. Khafaga70,

Walaa M. El-Lawaty71,

Mohamed S. Torky71,

Mohamed R. El-shanshory72

Admin Team Member

Amr M. Yassen73,

Mohamed A.F. Hegazy68,

Kamal Okasha74,

Mohammed A. Eid75,

Hanteera S. Moahmed71

EraCORE

Analysis Team Lead

Carolina Medina-Gomez76

Data Collection Lead

M. Arfan Ikram77

Admin Team Lead

Andre G Uitterlinden76,77

Estonian Biobank

Analysis Team Lead

Reedik Mägi78

Data Collection Lead

Lili Milani78

Admin Team Lead

Andres Metspalu78

Analysis Team Member

Triin Laisk78,

Kristi Läll78,

Maarja Lepamets78

Data Collection Member

Tõnu Esko78,

Ene Reimann78,

Paul Naaber79,

Edward Laane80,81,

Jaana Pesukova80,

Pärt Peterson82,

Kai Kisand83,

Jekaterina Tabri84,

Raili Allos84,

Kati Hensen84,

Joel Starkopf85,

Inge Ringmets86,

Anu Tamm87,

Anne Kallaste87

Admin Team Member

Helene Alavere78,

Kristjan Metsalu78,

Mairo Puusepp78

EXCEED

Analysis Team Lead

Chiara Batini88

Data Collection Lead

Martin D Tobin88,89

Admin Team Lead

Laura D Venn88

Analysis Team Member

Paul H Lee88,

Nick Shrine88,

Alexander T Williams88

Data Collection Member

Anna L Guyatt88,

Catherine John88,

Richard J Packer88,

Altaf Ali88,

Robert C Free90,

Xueyang Wang88,

Louise V Wain88,89,

Edward J Hollox91

Admin Team Member

Catherine E Bee88,

Emma L Adams88

FinnGen

Admin Team Lead

FinnGen92

Analysis Team Member

Samuli Ripatti3,93,94,95,

Sanni Ruotsalainen93

Data Collection Member

Kati Kristiansson96,

Sami Koskelainen96,

Markus Perola96,97,

Kati Donner7,

Katja Kivinen7,

Aarno Palotie7

Admin Team Member

Mari Kaunisto7

Functional Host Genomics in Infectious Diseases (FHoGID)

Analysis Team Lead

Carlo Rivolta98,99

Data Collection Lead

Pierre-Yves Bochud100,

Stéphanie Bibert101,

Noémie Boillat100,

Semira Gonseth Nussle102,

Werner Albrich103

Analysis Team Member

Mathieu Quinodoz98,99,

Dhryata Kamdar98,99

Data Collection Member

Noémie Suh104,

Dionysios Neofytos105,

Véronique Erard106,

Cathy Voide107,

FHoGID108,

RegCOVID109,

P-PredictUs110,

SeroCOVID111,

CRiPSI112

GCAT. Genomes For Life

Analysis Team Lead

Rafael de Cid113

Data Collection Lead

Anna Carreras113,

Victor Moreno114,

Manolis Kogevinas115,116,117,118

Analysis Team Member

Iván Galván-Femenía113,

Natalia Blay113,

Xavier Farré113,

Lauro Sumoy113

Data Collection Member

Beatriz Cortés113,

Josep Maria Mercader119,

Marta Guindo-Martinez120,

David Torrents120,

Judith Garcia-Aymerich115,117,118,

Gemma Castaño-Vinyals115,116,117,118,

Carlota Dobaño115,118

GEN-COVID Multicenter Study

Analysis Team Lead

Marco Gori121,122,

Mari E.K. Niemi12

Data Collection Lead

Alessandra Renieri123,124,125,

Francesca Mari123,124,125,

Mario Umberto Mondelli126,127,

Francesco Castelli128,

Massimo Vaghi129,

Stefano Rusconi130,131,

Francesca Montagnani132,133,

Elena Bargagli134,

Federico Franchi135,

Maria Antonietta Mazzei136,

Luca Cantarini137,

Danilo Tacconi138,

Marco Feri139,

Raffaele Scala140,

Genni Spargi141,

Cesira Nencioni142,

Maria Bandini143,

Gian Piero Caldarelli144,

Anna Canaccini145,

Agostino Ognibene146,

Antonella D’Arminio Monforte147,

Massimo Girardis148,

Andrea Antinori149,

Daniela Francisci150,151,

Elisabetta Schiaroli150,151,

Pier Giorgio Scotton152,

Sandro Panese153,

Renzo Scaggiante154,

Matteo Della Monica155,

Mario Capasso156,157,158,

Giuseppe Fiorentino159,

Marco Castori160,

Filippo Aucella161,

Antonio Di Biagio162,

Luca Masucci163,164,

Serafina Valente165,

Marco Mandalà166,

Patrizia Zucchi167,

Ferdinando Giannattasio168,

Domenico A. Coviello169,

Cristina Mussini170,

Luisa Tavecchia171,

Lia Crotti172,173,174,175,

Marco Rizzi176,

Maria Teresa La Rovere177,

Simona Sarzi-Braga178,

Maurizio Bussotti179,

Sabrina Ravaglia180,

Rosangela Artuso181,

Antonio Perrella182,

Davide Romani183,

Paola Bergomi184,

Emanuele Catena184,

Antonella Vincenti185,

Claudio Ferri186,

Davide Grassi186,

Gloria Pessina187,

Mario Tumbarello132,188,

Massimo Di Pietro189,

Ravaglia Sabrina190,

Sauro Luchi191

Admin Team Lead

Simone Furini125,

Simona Dei192

Analysis Team Member

Elisa Benetti125,

Nicola Picchiotti121,193,

Maurizio Sanarico194,

Stefano Ceri195,

Pietro Pinoli195,

Francesco Raimondi196,

Filippo Biscarini197,

Alessandra Stella198,

Kristina Zguro199,

Katia Capitani132,200,

Mattia Cordioli16,

Sara Pigazzini12,

Mattia Cordioli16,

Sara Pigazzini12,

Lindokuhle Nkambule17,64,

Marco Tanfoni121

Data Collection Member

Chiara Fallerini123,125,

Sergio Daga123,125,

Margherita Baldassarri123,125,

Francesca Fava123,124,125,

Elisa Frullanti123,125,

Floriana Valentino123,125,

Gabriella Doddato123,125,

Annarita Giliberti123,125,

Rossella Tita201,

Sara Amitrano201,

Mirella Bruttini123,132,201,

Susanna Croci123,125,

Ilaria Meloni123,125,

Maria Antonietta Mencarelli201,

Caterina Lo Rizzo201,

Anna Maria Pinto201,

Giada Beligni123,125,

Andrea Tommasi202,

Laura Di Sarno123,125,

Maria Palmieri123,125,

Miriam Lucia Carriero123,125,

Diana Alaverdian123,125,

Stefano Busani148,

Raffaele Bruno126,127,

Marco Vecchia203,

Mary Ann Belli171,

Stefania Mantovani203,

Serena Ludovisi204,

Eugenia Quiros-Roldan128,

Melania Degli Antoni128,

Isabella Zanella205,206,

Matteo Siano131,

Arianna Emiliozzi149,

Massimiliano Fabbiani133,

Barbara Rossetti133,

Laura Bergantini134,

Miriana D’Alessandro134,

Paolo Cameli134,

David Bennett134,

Federico Anedda135,

Simona Marcantonio135,

Sabino Scolletta135,

Susanna Guerrini136,

Edoardo Conticini137,

Bruno Frediani137,

Chiara Spertilli138,

Alice Donati139,

Luca Guidelli140,

Marta Corridi141,

Leonardo Croci142,

Paolo Piacentini143,

Elena Desanctis143,

Silvia Cappelli143,

Agnese Verzuri145,

Valentina Anemoli145,

Alessandro Pancrazzi146,

Maria Lorubbio146,

Federica Gaia Miraglia147,

Sophie Venturelli148,

Andrea Cossarizza207,

Alessandra Vergori149,

Arianna Gabrieli131,

Agostino Riva130,131,

Francesco Paciosi151,

Francesca Andretta152,

Francesca Gatti154,

Saverio Giuseppe Parisi208,

Stefano Baratti208,

Carmelo Piscopo155,

Roberta Russo156,157,

Immacolata Andolfo156,157,

Achille Iolascon156,157,

Massimo Carella160,

Giuseppe Merla156,209,

Gabriella Maria Squeo209,

Pamela Raggi210,

Carmen Marciano210,

Rita Perna210,

Matteo Bassetti162,211,

Maurizio Sanguinetti163,164,

Alessia Giorli166,

Lorenzo Salerni166,

Pierpaolo Parravicini167,

Elisabetta Menatti212,

Tullio Trotta168,

Gabriella Coiro168,

Fabio Lena213,

Enrico Martinelli214,

Sandro Mancarella171,

Chiara Gabbi194,

Franco Maggiolo176,

Diego Ripamonti176,

Tiziana Bachetti215,

Claudia Suardi216,

Gianfranco Parati173,217,

Giordano Bottà218,

Paolo Di Domenico218,

Ilaria Rancan219,

Francesco Bianchi132,182,

Riccardo Colombo184,

Chiara Barbieri220,

Donatella Acquilini221,

Elena Andreucci181,

Francesco Paciosi151,

Francesco Vladimiro Segala222,

Giusy Tiseo220,

Marco Falcone220,

Mirjam Lista132,223,

Monica Poscente187,

Oreste De Vivo165,

Paola Petrocelli224,

Alessandra Guarnaccia163,

Silvia Baroni225

Generation Scotland

Analysis Team Lead

Caroline Hayward226

Data Collection Lead

David J Porteous227

Admin Team Lead

Chloe Fawns-Ritchie228

Analysis Team Member

Anne Richmond226

Data Collection Member

Archie Campbell227

Genes & Health

Analysis Team Lead

David A van Heel229

Data Collection Lead

Karen A Hunt229

Admin Team Lead

Richard C Trembath230

Analysis Team Member

Qin Qin Huang231,

Hilary C Martin231

Data Collection Member

Dan Mason232,

Bhavi Trivedi233,

John Wright232

Admin Team Member

Sarah Finer234,

Genes & Health Research Team235,

Christopher J Griffiths236

Genes for Good

Analysis Team Lead

Albert V Smith237

Data Collection Member

Andrew P Boughton237,

Kevin W. Li237,

Jonathon LeFaive237,

Aubrey Annis237

Genome-wide assessment of the gene variants associated with severe COVID-19 phenotype in Iran

Analysis Team Lead

Mari E.K. Niemi12,

Ahmadreza Niavarani238

Data Collection Lead

Rasoul Aliannejad239

Analysis Team Member

Mattia Cordioli7,

Lindokuhle Nkambul17,64,

Bahareh Sharififard238

Data Collection Member

Ali Amirsavadkouhi240,

Zeinab Naderpour239,

Hengameh Ansari Tadi241,

Afshar Etemadi Aleagha242,

Saeideh Ahmadi243,

Seyed Behrooz Mohseni Moghaddam244,

Alireza Adamsara245,

Morteza Saeedi246,

Hamed Abdollahi247,

Abdolmajid Hosseini248

Host genetic factors in COVID-19 patients in relation to disease susceptibility, disease severity and pharmacogenomics

Analysis Team Lead

Pajaree Chariyavilaskul249,250

Data Collection Lead

Watsamon Jantarabenjakul251,252

Admin Team Lead

Nattiya Hirankarn253,254

Analysis Team Member

Monpat Chamnanphon255,256,

Thitima B. Suttichet255,

Vorasuk Shotelersuk257,258,

Monnat Pongpanich259,260,

Chureerat Phokaew258,261,262,

Wanna Chetruengchai258,262

Data Collection Member

Opass Putchareon251,263,

Pattama Torvorapanit251,263,

Thanyawee Puthanakit252,264,

Pintip Suchartlikitwong264,265

Admin Team Member

Voraphoj Nilaratanakul266,267,

Pimpayao Sodsai253,254

HUNT

Analysis Team Lead

Ben M Brumpton268,269,270

Data Collection Lead

Kristian Hveem268,269,

Cristen Willer271,272,273

Analysis Team Member

Brooke Wolford271,272,273,

Wei Zhou274,275

Data Collection Member Tormod Rogne276,277,278,

Erik Solligard276,278,

Bjørn Olav Åsvold268,269,270

Lifelines

Analysis Team Lead

Lude Franke279

Data Collection Lead

Marike Boezen280

Analysis Team Member

Patrick Deelen281,

Annique Claringbould279,

Esteban Lopera279,

Robert Warmerdam279,

Judith. M. Vonk282,

Irene van Blokland279

Data Collection Member

Pauline Lanting283,

Anil P. S. Ori284,285

Mass General Brigham - Host Vulnerability to COVID-19

Analysis Team Lead

Yen-Chen Anne Feng286,

Josep Mercader287,288

Data Collection Lead

Scott T Weiss289,

Elizabeth W. Karlson290,

Jordan W. Smoller291,

Shawn N Murphy292,

James B. Meigs293,

Ann E. Woolley290

Admin Team Lead

Robert C. Green294

Data Collection Member

Emma F Perez295

Michigan Genomics Initiative (MGI)

Analysis Team Lead

Brooke Wolford273

Admin Team Lead

Sebastian Zöllner237

Analysis Team Member

Jiongming Wang237,

Andrew Beck237

Mount Sinai Health System COVID-19 Genomics Initiative

Analysis Team Lead

Laura G. Sloofman296,297,298

Data Collection Lead

Steven Ascolillo299,

Robert P. Sebra300,301,

Brett L. Collins302,

Tess Levy302

Admin Team Lead

Joseph D. Buxbaum302,

Stuart C. Sealfon298

Analysis Team Member

Shea J. Andrews6,

Daniel M. Jordan303,304,

Ryan C. Thompson305,306,307,

Kyle Gettler308,

Kumardeep Chaudhary304,309,

Gillian M. Belbin310,

Michael Preuss311,312,

Clive Hoggart298,313,

Sam Choi314,

Slayton J. Underwood298,315

Data Collection Member

Irene Salib300,

Bari Britvan302,

Katherine Keller302,

Lara Tang302,

Michael Peruggia302,

Liam L. Hiester302,

Kristi Niblo302,

Alexandra Aksentijevich302,

Alexander Labkowsky302,

Avromie Karp302,

Menachem Zlatopolsky302,

Marissa Zyndorf300

Admin Team Member

Alexander W. Charney316,

Noam D. Beckmann299,

Eric E. Schadt300,301,

Noura S. Abul-Husn310,

Judy H. Cho304,309,

Yuval Itan304,309,

Eimear E. Kenny310,

Ruth J.F. Loos311,312,317,

Girish N. Nadkarni311,318,319,320,321,

Ron Do304,309,

Paul O’Reilly314,

Laura M. Huckins322

MyCode Health Initiative

Analysis Team Lead

Manuel A.R. Ferreira323,

Goncalo R. Abecasis323

Data Collection Lead

Joseph B. Leader324,

Michael N. Cantor323

Admin Team Lead

Anne E Justice325,

Dave J. Carey326

Analysis Team Member

Geetha Chittoor325,

Navya Shilpa Josyula325,

Jack A. Kosmicki323,

Julie E Horowitz323,

Aris Baras323

Data Collection Member

Matthew C. Gass324,

Ashish Yadav323

Admin Team Member

Tooraj Mirshahi326

Netherlands Twin Register

Analysis Team Lead

Jouke Jan Hottenga327

Data Collection Lead

Meike Bartels327

Admin Team Lead

Eco (E.J.C.) de geus327

Analysis Team Member

Michel (M.G.) Nivard327

Penn Medicine Biobank

Analysis Team Lead

Anurag Verma328,

Marylyn D. Ritchie328

Admin Team Lead

Daniel Rader328

Analysis Team Member

Binglan Li329,

Shefali S Verma328,

Anastasia Lucas328,

Yuki Bradford328

Saudi Human Genome Program-COVID19 : Host Genomic markers predicting the severity and suitability to COVID-19 in highly consanguineous population

Analysis Team Lead

Malak Abedalthagafi330,

Manal Alaamery331

Data Collection Lead

Abdulraheem Alshareef332,

Mona Sawaji333

Admin Team Lead

Salam Massadeh331,

Abdulaziz AlMalik334

Analysis Team Member

Saleh Alqahtani335,

Dona Baraka336,

Fawz Al Harthi330,

Ebtehal Alsolm330,

Leen Abu Safieh330,

Albandary M Alowayn330,

Fatimah Alqubaishi330,

Amal Al Mutairi330,

Serghei Mangul337

Data Collection Member

Mansour Almutairi331,

Nora Aljawini338,

Nour Albesher338,

Yaseen M Arabi339,

Ebrahim S Mahmoud339,

Amin K Khattab340,

Roaa T Halawani340,

Ziab Z Alahmadey340,

Jehad K Albakri340,

Walaa A Felemban340,

Bandar A Suliman332,

Rana Hasanato336,

Laila Al-Awdah341,

Jahad Alghamdi342,

Deema AlZahrani343,

Sameera AlJohani344,

Hani Al-Afghani345,

Nouf AlDhawi343,

Hadeel AlBardis330,

Sarah Alkwai338,

Moneera Alswailm338,

Faisal Almalki343,

Maha Albeladi343,

Iman Almohammed338,

Eman Barhoush346,

Anoud Albader343

Admin Team Member

Sara Alotaibi330,

Bader Alghamdi347,

Junghyun Jung348,

Mohammad S fawzy330

Data collection Member

May Alrashed349

The genetic predisposition to severe COVID-19

Analysis Team Lead

Mari E.K. Niemi12

Data Collection Lead

Hugo Zeberg350,351

Analysis Team Member

Mattia Cordioli16,

Sara Pigazzini12,

Lindo Nkambul3,17,352

Data Collection Member

Robert Frithiof353,

Michael Hultström353,354,

Miklos Lipcsey353,355,

Nicolas Tardif356,

Olav Rooyackers356,

Jonathan Grip356,

Tomislav Maricic351

The Norwegian Mother, Father and Child Cohort Study

Analysis Team Lead

øyvind Helgeland357

Data Collection Lead

Per Magnus358,

Lill-Iren S Trogstad359

Analysis Team Member

Yunsung Lee358

Admin Team Member

Jennifer R Harris357

TwinsUK

Analysis Team Lead

Massimo Mangino360,361

Data Collection Lead

Tim D Spector360

Data Collection Member

Duncan Emma360

UK 100,000 Genomes Project (Genomics England)

Analysis Team Lead

Loukas Moutsianas362,363

Data Collection Lead

Mark J Caulfield362,363,364,

Richard H Scott362,365

Analysis Team Member

Athanasios Kousathanas366,

Dorota Pasko366,

Susan Walker366,

Alex Stuckey366,

Christopher A Odhams366,

Daniel Rhodes366

Data Collection Member

Tom Fowler366,

Augusto Rendon362,367,

Georgia Chan366,

Prabhu Arumugam366

UK Biobank

Analysis Team Lead

Tomoko Nakanishi368,

Konrad J. Karczewski5,19,

Alicia R. Martin5,19,

Daniel J Wilson369,

Chris C A Spencer370

Data Collection Lead

Derrick W Crook371,

David H Wyllie371,372,

Anne Marie O’Connell373

Admin Team Lead

J. Brent Richards24,28,29

Analysis Team Member

Guillaume Butler-Laporte24,30,

Vincenzo Forgetta24,

Elizabeth G. Atkinson5,19,

Masahiro Kanai5,19,374,

Kristin Tsuo5,19,375,

Nikolas Baya5,19,

Patrick Turley5,19,

Rahul Gupta5,19,

Raymond K. Walters5,19,

Duncan S. Palmer5,19,

Gopal Sarma5,19,

Matthew Solomonson5,19,

Nathan Cheng5,19,

Wenhan Lu5,19,

Claire Churchhouse5,19,

Jacqueline I. Goldstein5,19,

Daniel King5,19,

Wei Zhou5,19,

Cotton Seed5,19,

Mark J. Daly2,3,5,

Benjamin M. Neale5,19,

Hilary Finucane5,19,

Sam Bryant3,

F. Kyle Satterstrom5,19,

Gavin Band376,

Sarah G Earle369,

Shang-Kuan Lin369,

Nicolas Arning369,

Nils Koelling370

Data Collection Member

Jacob Armstrong369,

Justine K Rudkin369

Admin Team Member

Shawneequa Callier377,

Sam Bryant5,19,

Caroline Cusick19

UK Blood Donors Cohort

Analysis Team Lead

Nicole Soranzo378,379,380,

Jing Hua Zhao381

Data Collection Lead

John Danesh381,382,383,384,385,

Emanuele Di Angelantonio381,382,383,384

Analysis Team Member

Adam S. Butterworth381,382,383,384

VA Million Veteran Program (MVP)

Analysis Team Lead

Yan V Sun386,387,

Jennifer E Huffman388

Data Collection Lead

Kelly Cho389

Admin Team Lead

Christopher J O’Donnell388,

Phil Tsao390,391,

J. Michael Gaziano389

Analysis Team Member

Gina Peloso388,392

Data Collection Member

Yuk-Lam Ho389

Vanda COVID

Analysis Team Lead

Sandra P Smieszek393

Admin Team Lead

Christos Polymeropoulos393,

Vasilios Polymeropoulos393,

Mihael H Polymeropoulos393

Analysis Team Member

Bartlomiej P Przychodzen393

Variability in immune response genes and severity of SARS-CoV-2 infection (INMUNGEN-CoV2 study)

Analysis Team Lead

Israel Fernandez-Cadenas394

Data Collection Lead

Anna M Planas395,396

Analysis Team Member

Jordi Perez-Tur397,398,399,

Laia Llucià-Carol394,400,

Natalia Cullell394,401,

Elena Muiño394,

Jara Cárcel-Márquez394,

Marta L DeDiego402,

Lara Lloret Iglesias403

Data Collection Member

Alex Soriano404,

Veronica Rico405,

Daiana Agüero405,

Josep L Bedini405,

Francisco Lozano406,

Carlos Domingo405,

Veronica Robles405,

Francisca Ruiz-Jaén407,

Leonardo Márquez408,

Juan Gomez409,

Eliecer Coto409,

Guillermo M Albaiceta409,

Marta García-Clemente409,

David Dalmau410,

Maria J Arranz410,

Beatriz Dietl410,

Alex Serra-Llovich410,

Pere Soler411,

Roger Colobrán411,

Andrea Martín-Nalda411,

Alba Parra Martínez411,

David Bernardo412,

Silvia Rojo413,

Aida Fiz-López412,

Elisa Arribas412,

Paloma de la Cal-Sabater412,

Tomás Segura414,

Esther González-Villa415,

Gemma Serrano-Heras416,

Joan Martí-Fàbregas417,

Elena Jiménez-Xarrié417,

Alicia de Felipe Mimbrera418,

Jaime Masjuan418,

Sebastian García-Madrona418,

Anna Domínguez-Mayoral419,

Joan Montaner Villalonga419,

Paloma Menéndez-Valladares419

Women’s Genome Health Study (WGHS), i.e. the genomics subset of Women’s Health Study (WHS)

Analysis Team Lead

Daniel I. Chasman420,421

Data Collection Lead

Howard D. Sesso420,421,

JoAnn E. Manson420,421

Admin Team Lead

Julie E. Buring420,421,

Paul M Ridker420,421

Analysis Team Member

Giulianini Franco420

COVID-19 HGI corresponding authors

COVID-19 HGI corresponding authors

Benjamin M Neale4,

Mark Daly2,3,5,

Andrea Ganna2,3,5

  1. Yale University, New Haven, CT, USA

  2. Institute for Molecular Medicine Finland (FIMM), Univerisity of Helsinki, Helsinki, Finland

  3. Broad Institute of MIT and Harvard, Cambridge, MA, USA

  4. Massachusetts General Hospital, Broad Institute of MIT and Harvard, Cambridge, MA, USA

  5. Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA

  6. Icahn School of Medicine at Mount Sinai, New York, NY, USA

  7. Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland

  8. Icahn School of Medicine at Mount Sinai, Genetics and Genomic Sciences

  9. Centre for Bioinformatics and Data Analysis, Medical University of Bialystok, Bialystok, Poland

  10. University of Michigan, Ann Arbor, MI, USA

  11. Ancestry, Lehi, UT, USA

  12. Institute for Molecular Medicine Finland (FIMM), Helsinki, Finland

  13. University of Liege, GIGA-Institute, Liège, Belgium

  14. CHC Mont-Légia, Liège, Belgium

  15. 5BHUL (Liège Biobank), CHU of Liège, Liège, Belgium

  16. Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland

  17. Analytic & Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA

  18. Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA

  19. Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA

  20. CHU of Liege, Liège, Belgium

  21. University of Liege, Liège, Belgium

  22. CHU of liege, Liège, Belgium

  23. Department of Human Genetics, McGill University, Montréal, Québec, Canada

  24. Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada

  25. Kyoto-McGill International Collaborative School in Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan

  26. Research Fellow, Japan Society for the Promotion of Science

  27. McGill Genome Centre and Department of Human Genetics, McGill University, Montréal, Québec, Canada

  28. Department of Human Genetics, Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada

  29. Department of Twin Research, King’s College London, London, United Kingdom

  30. Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada

  31. Department of Emergency Medicine, McGill University, Montréal, Québec, Canada

  32. Emergency Department, Jewish General Hospital, McGill University, Montréal, Québec, Canada

  33. McGill AIDS Centre, Department of Microbiology and Immunology, Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montréal, Québec, Canada

  34. McGill Centre for Viral Diseases, Lady Davis Institute, Department of Infectious Disease, Jewish General Hospital, Montréal, Québec, Canada

  35. Research Centre of the Centre Hospitalier de l’Université de Montréal, Montréal, Canada

  36. Department of Medicine,Research Centre of the Centre Hospitalier de l’Université de Montréal, Montréal, Canada

  37. Department of Medicine, Université de Montréal, Montréal, Canada

  38. Department of Medicine and Human Genetics, McGill University, Montréal, Québec, Canada

  39. Department of Intensive Care, Research Centre of the Centre Hospitalier de l’Université de Montréal, Montréal, Canada

  40. Division of Infectious Diseases, Research Centre of the Centre Hospitalier de l’Université de Montréal, Montréal, Canada

  41. MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Western General Hospital, Edinburgh, UK EH4 2XU

  42. Center for Applied Genomics, Children’s Hospital of Philadelphia, Philadelphia, PA, USA

  43. Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

  44. Vanderbilt University Medical Center

  45. Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Western General Hospital, Edinburgh, UK, EH4 2XU, Usher Institute, University of Edinburgh, Nine, Edinburgh Bioquarter, 9 Little France Road, Edinburgh, UK, EH16 4UX

  46. University of Texas Health

  47. Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Western General Hospital, Edinburgh, UK, EH4 2XU

  48. Department of Psychology, University of Edinburgh, Edinburgh, UK, EH8 9JZ, Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Western General Hospital, Edinburgh, UK, EH4 2XU

  49. University of North Carolina at Chapel Hill

  50. Center for Applied Genomics, The Children’s Hospital of Philadelphia, Philadelphia, PA, USA

  51. Center for Applied Genomics, The Children’s Hospital of Philadelphia, Philadelphia, PA, USA

  52. Division of Human Genetics, Department of Pediatrics, The Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

  53. Divisions of Human Genetics and Pulmonary Medicine, Department of Pediatrics, The Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

  54. Faculty of Medicine, University of Iceland, Reykjavik, Iceland

  55. University of Colorado - Anschutz Medical Campus, Aurora, CO, USA

  56. MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Western General Hospital, Edinburgh, Scotland

  57. Centre for Global Health Research, Usher Institute, University of Edinburgh, Teviot Place, Edinburgh, Scotland

  58. The Roslin Institute, The Royal (Dick) School of Veterinary Studies, University of Edinburgh, Edinburgh, UK

  59. Department of Clinical Pathology, Faculty of Medicine, Mansoura University, Mansoura, Egypt.

  60. Department of Biosciences, School of Science and Technology, Nottingham Trent University, Nottingham, UK

  61. Genolier Innovation Network and Hub, Swiss Medical Network, Genolier Healthcare Campus, Route du Muids 3, 1272 Genolier, Switzerland.

  62. Department of Pediatrics, Faculty of Medicine, Mansoura University, Mansoura, Egypt.

  63. Department of Clinical Pathology, Faculty of Medicine, Tanta University, Tanta, Egypt.

  64. Stanley Center for Psychiatric Research & Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA

  65. Chest Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt.

  66. Anesthesia, Surgical Intensive Care & Pain Management Department, Faculty of Medicine, Tanta University, Tanta, Egypt.

  67. Department of Medical Biochemistry, Faculty of Medicine, Mansoura University, Mansoura, Egypt.

  68. Department of Surgery, Faculty of Medicine, Mansoura University, Mansoura, Egypt.

  69. Department of Tropical Medicine, Faculty of Medicine, Mansoura University, Mansoura, Egypt.

  70. pediatric and neonatology, Kafr Elzayat General Hospital, Kafr El-Zayat, Egypt.

  71. Chest Department, Faculty of Medicine, Tanta University, Tanta, Egypt.

  72. Pediatrics Department, Faculty of Medicine, Tanta University, Tanta, Egypt.

  73. Department of Anaethesia and Critical Care, Faculty of Medicine, Mansoura University, Mansoura, Egypt.

  74. Department of Internal Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt.

  75. Faculty of Science, Tanta University, Tanta, Egypt.

  76. Department of Internal Medicine

  77. Department of Epidemiology

  78. Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia

  79. SYNLAB Estonia, University of Tartu, Tartu, Estonia

  80. Kuressaare Hospital, Kuressaare, Estonia

  81. University of Tartu, Tartu, Estonia

  82. Institute of Biomedicine and Translational Medicine, University of Tartu

  83. Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia

  84. West Tallinn Central Hospital, Tallinn, Estonia

  85. University of Tartu, Tartu University Hospital, Tartu, Estonia

  86. Estonian Health Insurance Fund, Tallinn, Estonia

  87. Tartu University Hospital, Tartu, Estonia

  88. Department of Health Sciences, University of Leicester, Leicester, UK

  89. Leicester NIHR Biomedical Research Centre, Leicester, UK

  90. Department of Respiratory Sciences, University of Leicester, UK

  91. Department of Genetics and Genome Biology, University of Leicester

  92. FinnGen, Helsinki, Finland

  93. Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Finland

  94. Public Health, Faculty of Medicine, University of Helsinki, Finland 95.

  95. Finnish Institute for Health and Welfare (THL), Helsinki, Finland

  96. University of Helsinki, Faculty of Medicine, Clinical and Molecular Metabolism Research Program, Helsinki, Finland

  97. Institute of Molecular and Clinical Ophthalmology Basel (IOB), Basel, Switzerland

  98. Department of Ophthalmology, University of Basel, Basel, Switzerland

  99. Infectious Diseases Service, Department of Medicine, University Hospital and University of Lausanne, Lausanne, Switzerland

  100. Infectious Diseases Service, Department of Medicine, University Hospital, University of Lausanne, Lausanne, Switzerland

  101. Centre for Primary Care and Public Health, University of Lausanne, Lausanne, Switzerland.

  102. Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, St Gallen, Switzerland.

  103. Division of Intensive Care, Geneva University Hospitals and the University of Geneva Faculty of Medicine, Geneva, Switzerland.

  104. Infectious Disease Service, Department of Internal Medicine, Geneva University Hospital, Geneva, Switzerland.

  105. Clinique de Médecine et spécialités, Infectiologie, HFR-Fribourg, Fribourg, Switzerland

  106. Infectious Diseases Division, University Hospital Centre of the canton of Vaud, hospital of Valais, Sion, Switzerland

  107. Functional Host Genomics of Infectious Diseases, University Hospital and University of Lausanne, Lausanne, Switzerland

  108. Registry COVID, University Hospital and University of Lausanne, Lausanne, Switzerland

  109. Pneumonia prediction using lung ultrasound, University Hospital and University of Lausanne, Lausanne, Switzerland

  110. Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland

  111. Covid-19 Risk Prediction in Swiss ICUs-Trial, Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, St Gallen, Switzerland.

  112. GCAT-Genomes for Life, Germans Trias i Pujol Health Sciences Research Institute (IGTP), Crta. de Can Ruti, Cami de les Escoles s/n.08916 Badalona, Catalonia

  113. Catalan Institute of Oncology,Bellvitge Biomedical Research Institute, Consortium for Biomedical Research in Epidemiology and Public Health and University of Barcelona, Barcelona, Spain

  114. ISGlobal, Barcelona, Spain

  115. IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain

  116. Universitat Pompeu Fabra (UPF), Barcelona, Spain

  117. CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain

  118. Barcelona Supercomputing Center - Centro Nacional de Supercomputación (BSC-CNS).Life & Medical Sciences *currently at Programs in Metabolism and Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA and Diabetes Unit and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA. Harvard Medical School, Boston, Massachusetts, USA

  119. Barcelona Supercomputing Center - Centro Nacional de Supercomputación (BSC-CNS).Life & Medical Sciences, Barcelona, Spain

  120. University of Siena, DIISM-SAILAB, Siena, Italy

  121. Université Côte d’Azur, Inria, CNRS, I3S, Maasai, Nice, France

  122. Medical Genetics, University of Siena, Italy

  123. Genetica Medica, Azienda Ospedaliero-Universitaria Senese, Italy

  124. Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Siena, Italy

  125. Division of Infectious Diseases and Immunology, Department of Medical Sciences and Infectious Diseases, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

  126. Department of Internal Medicine and Therapeutics, University of Pavia, Italy

  127. Department of Infectious and Tropical Diseases, University of Brescia and ASST Spedali Civili Hospital, Brescia, Italy

  128. Chirurgia Vascolare, Ospedale Maggiore di Crema, Crema, Italy

  129. III Infectious Diseases Unit, ASST-FBF-Sacco, Milan, Italy

  130. Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Milan, Italy

  131. Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Italy

  132. Dept of Specialized and Internal Medicine, Tropical and Infectious Diseases Unit, Azienda Ospedaliera Universitaria Senese, Siena, Italy

  133. Unit of Respiratory Diseases and Lung Transplantation, Department of Internal and Specialist Medicine, University of Siena, Siena, Italy

  134. Dept of Emergency and Urgency, Medicine, Surgery and Neurosciences, Unit of Intensive Care Medicine, Siena University Hospital, Siena, Italy

  135. Department of Medical, Surgical and Neuro Sciences and Radiological Sciences, Unit of Diagnostic Imaging, University of Siena, Siena, Italy

  136. Rheumatology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Policlinico Le Scotte, Siena, Italy

  137. Department of Specialized and Internal Medicine, Infectious Diseases Unit, San Donato Hospital Arezzo, Arezzo, Italy

  138. Dept of Emergency, Anesthesia Unit, San Donato Hospital, Arezzo, Italy

  139. Department of Specialized and Internal Medicine, Pneumology Unit and UTIP, San Donato Hospital, Arezzo, Italy

  140. Department of Emergency, Anesthesia Unit, Misericordia Hospital, Grosseto, Italy

  141. Department of Specialized and Internal Medicine, Infectious Diseases Unit, Misericordia Hospital, Grosseto, Italy

  142. Department of Preventive Medicine, Azienda USL Toscana Sud Est, Arezzo, Italy

  143. Clinical Chemical Analysis Laboratory, Misericordia Hospital, Grosseto, Italy

  144. Territorial Scientific Technician Department, Azienda USL Toscana Sud Est, Arezzo, Italy

  145. Clinical Chemical Analysis Laboratory, San Donato Hospital, Arezzo, Italy

  146. Department of Health Sciences, Clinic of Infectious Diseases, ASST Santi Paolo e Carlo, University of Milan, Milan, Italy

  147. Department of Anesthesia and Intensive Care, University of Modena and Reggio Emilia, Modena, Italy

  148. HIV/AIDS Department, National Institute for Infectious Diseases, IRCCS, Lazzaro Spallanzani, Rome, Italy

  149. Infectious Diseases Clinic, Department of Medicine 2, Azienda Ospedaliera di Perugia and University of Perugia, Santa Maria Hospital, Perugia, Italy

  150. Infectious Diseases Clinic, “Santa Maria” Hospital, University of Perugia, Perugia, Italy

  151. Department of Infectious Diseases, Treviso Hospital, Treviso, Italy

  152. Clinical Infectious Diseases, Mestre Hospital, Venezia, Italy

  153. Infectious Diseases Clinic, ULSS1, Belluno, Italy

  154. Medical Genetics and Laboratory of Medical Genetics Unit, A.O.R.N. “Antonio Cardarelli”, Naples, Italy

  155. Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy

  156. CEINGE Biotecnologie Avanzate, Naples, Italy

  157. IRCCS SDN, Naples, Italy

  158. Unit of Respiratory Physiopathology, AORN dei Colli, Monaldi Hospital, Naples, Italy

  159. Division of Medical Genetics, Fondazione IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo, Italy

  160. Department of Medical Sciences, Fondazione IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo, Italy

  161. Infectious Diseases Clinic, Policlinico San Martino Hospital, IRCCS for Cancer Research, Genova, Italy

  162. Microbiology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Catholic University of Medicine, Rome, Italy

  163. Department of Laboratory Sciences and Infectious Diseases, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy

  164. Department of Cardiovascular Diseases, University of Siena, Siena, Italy

  165. Otolaryngology Unit, University of Siena, Siena, Italy

  166. Department of Internal Medicine, ASST Valtellina e Alto Lario, Sondrio, Italy

  167. First Aid Department, Luigi Curto Hospital, Polla, Salerno, Italy

  168. U.O.C. Laboratorio di Genetica Umana, IRCCS Istituto G. Gaslini, Genova, Italy

  169. Infectious Diseases Clinics, University of Modena and Reggio Emilia, Modena, Italy

  170. U.O.C. Medicina, ASST Nord Milano, Ospedale Bassini, Cinisello Balsamo (MI), Italy

  171. Department of Cardiovascular, Neural and Metabolic Sciences, Istituto Auxologico Italiano, IRCCS, San Luca Hospital, Milan, Italy

  172. Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy

  173. Istituto Auxologico Italiano, IRCCS, Center for Cardiac Arrhythmias of Genetic Origin, Milan, Italy

  174. Istituto Auxologico Italiano, IRCCS, Laboratory of Cardiovascular Genetics, Milan, Italy

  175. Unit of Infectious Diseases, ASST Papa Giovanni XXIII Hospital, Bergamo, Italy

  176. Department of Cardiology,Istituti Clinici Scientifici Maugeri IRCCS, Institute of Montescano, Pavia, Italy

  177. Istituti Clinici Scientifici Maugeri, IRCCS, Department of Cardiac Rehabilitation, Institute of Tradate (VA), Pavia, Italy

  178. Cardiac Rehabilitation Unit, Fondazione Salvatore Maugeri, IRCCS, Scientific Institute of Milan, Milan, Italy

  179. IRCCS C. Mondino Foundation, Pavia, Italy

  180. Medical Genetics Unit, Meyer Children’s University Hospital, Florence, Italy

  181. Department of Medicine, Pneumology Unit, Misericordia Hospital, Grosseto, Italy

  182. Department of Preventive Medicine, Azienda USL Toscana Sud Est, Tuscany, Italy

  183. Department of Anesthesia and Intensive Care Unit, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Polo Universitario, University of Milan, Milan, Italy

  184. Infectious Disease Unit, Hospital of Massa, Massa, Italy.

  185. Department of Clinical Medicine, Public Health, Life and Environment Sciences, University of L’Aquila, L’Aquila, Italy

  186. UOSD Laboratorio di Genetica Medica - ASL Viterbo, San Lorenzo, Italy

  187. Department of Medical Sciences, Infectious and Tropical Diseases Unit, Azienda Ospedaliera Universitaria Senese, Siena, Italy

  188. Unit of Infectious Diseases, S.M. Annunziata Hospital, Florence, Italy.

  189. IRCCS Mondino Foundation, Pavia, Italy.

  190. Infectious Disease Unit, Hospital of Lucca, Lucca, Italy

  191. Health Management, Azienda USL Toscana Sudest, Tuscany, Italy

  192. Department of Mathematics, University of Pavia, Pavia, Italy

  193. Independent Researcher, Milan, Italy

  194. Department of Electronics, Information and Bioengineering (DEIB), Politecnico di Milano, Milano, Italy

  195. Scuola Normale Superiore, Pisa, Italy

  196. CNR-Consiglio Nazionale delle Ricerche, Istituto di Biologia e Biotecnologia Agraria (IBBA), Milano, Italy

  197. CNR-Consiglio Nazionale delle Ricerche, Istituto di Biologia e Biotecnologia Agraria (IBBA), Milano, Italy

  198. Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena,Siena, Italy Italy

  199. Core Research Laboratory, ISPRO, Florence, Italy

  200. Genetica Medica, Azienda Ospedaliero-Universitaria Senese, Siena, Italy

  201. Infectious Diseases Clinic, Department of Medicine 2, Azienda Ospedaliera di Perugia and University of Perugia, Santa Maria Hospital

  202. Division of Infectious Diseases and Immunology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

  203. Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico

  204. Department of Molecular and Translational Medicine, University of Brescia, Italy

  205. Clinical Chemistry Laboratory, Cytogenetics and Molecular Genetics Section, Diagnostic Department, ASST Spedali Civili di Brescia, Brescia, Italy

  206. Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Modena, Italy

  207. Department of Molecular Medicine, University of Padova, Padua, Italy

  208. Laboratory of Regulatory and Functional Genomics, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo (Foggia), Italy

  209. Clinical Trial Office, Fondazione IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo, Italy

  210. Department of Health Sciences, University of Genova, Genova, Italy

  211. Oncologia Medica e Ufficio Flussi Sondrio, Sondrio, Italy

  212. Local Health Unit-Pharmaceutical Department of Grosseto, Toscana Sud Est Local Health Unit, Grosseto, Italy

  213. Department of Respiratory Diseases, Azienda Ospedaliera di Cremona, Cremona, Italy

  214. Direzione Scientifica, Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy

  215. Fondazione per la ricerca Ospedale di Bergamo, Bergamo, Italy

  216. Department of Cardiovascular, Neural and Metabolic Sciences,Istituto Auxologico Italiano, IRCCS, San Luca Hospital, Milan, Italy

  217. Allelica Inc, New York, NY, USA

  218. Dept of Specialized and Internal Medicine, Tropical and Infectious Diseases Unit, Azienda Ospedaliera Universitaria Senese, Siena, Italy

  219. Department of Clinical and Experimental Medicine, Infectious Diseases Unit, University of Pisa, Pisa, Italy.

  220. Infectious Disease Unit, Santo Stefano Hospital, AUSL Toscana Centro, Prato, Italy.

  221. Clinic of Infectious Diseases, Catholic University of the Sacred Heart, Rome, Italy.

  222. Medical Genetics, University of Siena, Siena, Italy

  223. Infectious Disease Unit, Hospital of Lucca, Lucca Italy.

  224. Department of Diagnostic and Laboratory Medicine, Institute of Biochemistry and Clinical Biochemistry, Fondazione Policlinico Universitario A. Gemelli IRCCS, Catholic University of the Sacred Heart, Rome, Italy.

  225. MRC Human Genetics Unit, IGC,University of Edinburgh.EH4 2XU,UK

  226. Medical Genetics Section, Centre for Genomic and Experimental Medicine, IGC, University of Edinburgh, Edinburgh, UK, Generation Scotland, Centre for Genomic and Experimental Medicine, IGC, University of Edinburgh, Edinburgh, UK

  227. Department of Psychology, University of Edinburgh, Edinburgh, UK, Medical Genetics Section, Centre for Genomic and Experimental Medicine, IGC, University of Edinburgh, Edinburgh, UK, Generation Scotland, Centre for Genomic and Experimental Medicine, IGC, University of Edinburgh, Edinburgh, UK

  228. Blizard Institute, Queen Mary University of London, London, United Kingdom

  229. School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine, King’s College London, London, United Kingdom

  230. Medical and Population Genomics, Wellcome Sanger Institute, Hinxton, UK

  231. Bradford Institute for Health Research, Bradford Teaching Hospitals National Health Service (NHS) Foundation Trust, Bradford, UK

  232. Blizard Institute, 4 Newark Street, Queen Mary University of London

  233. Institute of Population Health Sciences, 4 Newark Street, Queen Mary University of London, London, United Kingdom

  234. Genes & Health, Blizard Institute, Queen Mary University of London, E1 2AT, London, United Kingdom

  235. Institute of Population Health Sciences, 4 Newark Street, Queen Mary University of London

  236. Department of Biostatistics, University of Michigan, Ann Arbor, MI, USA

  237. Digestive Oncology Research Center, Digestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran

  238. Department of Pulmonology, School of Medicine, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran

  239. Department of Critical Care Medicine, Noorafshar Hospital, Tehran, Iran

  240. Department of Emergency Intensive Care Unit, School of Medicine, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran

  241. Department of Anesthesiology, School of Medicine, Amir Alam Hospital, Tehran University of Medical Sciences, Tehran, Iran

  242. Department of Pulmonology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

  243. Department of Pathology, Parseh Pathobiology and Genetics Laboratory, Tehran, Iran

  244. Department of Microbiology, Health and Family Research Center, NIOC Hospital, Tehran, Iran

  245. Department of Emergency Medicine, School of Medicine, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran

  246. Department of Anesthesiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

  247. Department of Pathology, Faculty of Medicine, Tehran Azad University, Tehran, Iran

  248. Clinical Pharmacokinetics and Pharmacogenomics Research Unit, Faculty of Medicine, Chulalongkorn University, Bangkok Thailand

  249. Department of Pharmacology, Faculty of Medicine, Chulalongkorn University, Bangkok Thailand

  250. Thai Red Cross Emerging Infectious Diseases Clinical Centre, King Chulalongkorn Memorial Hospital, Bangkok, Thailand

  251. Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

  252. Immunology Division, Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

  253. Center of Excellence in Immunology and Immune-mediated Diseases, Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

  254. Clinical Pharmacokinetics and Pharmacogenomics Research Unit, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

  255. Department of Pathology, Faculty of Medicine, Nakornnayok, Srinakharinwirot University, Thailand

  256. Center of Excellence for Medical Genomics, Medical Genomics Cluster, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

  257. Excellence Center for Genomics and Precision Medicine, King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand.

  258. Department of Mathematics and Computer Science, Faculty of Science, Chulalongkorn University, Bangkok, Thailand

  259. Omics Sciences and Bioinfomatics Center, Faculty of Science, Chulalongkorn University, Bangkok, Thailand

  260. Research Affairs, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

  261. Center of Excellence for Medical Genomics, Medical Genomics Cluster, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

  262. Division of Infectious Disease, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

  263. Center of Excellence in Pediatric Infectious Diseases and Vaccines, Chulalongkorn University, Bangkok, Thailand

  264. Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

  265. Division of Infectious Diseases, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

  266. Healthcare-associated Infection Research Group STAR (Special Task Force for Activating Research), Chulalongkorn University, Bangkok, Thailand

  267. K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, NTNU, Norwegian University of Science and Technology, Trondheim, 7030, Norway

  268. HUNT Research Center, Department of Public Health and Nursing, NTNU, Norwegian University of Science and Technology, Levanger, 7600, Norway

  269. Clinic of Medicine, St. Olavs Hospital, Trondheim University Hospital, Trondheim, 7030, Norway

  270. Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA

  271. Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA

  272. Department of Human Genetics, University of Michigan, Ann Arbor, MI, USA

  273. Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, Massachusetts, USA

  274. Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA

  275. Gemini Center for Sepsis Research, Department of Circulation and Medical Imaging, NTNU, Norwegian University of Science and Technology, Trondheim, Norway

  276. Department of Chronic Disease Epidemiology and Center for Perinatal, Pediatric and Environmental Epidemiology, Yale School of Public Health, New Haven, CT, USA

  277. Clinic of Anaesthesia and Intensive Care, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway

  278. Department of Genetics, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands

  279. Department of Epidemiology, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands

  280. Department of Genetics, University Medical Centre Groningen, University of Groningen / Department of Genetics, University Medical Centre Utrecht, P.O. Box 85500, 3508 GA, Utrecht, The Netherlands

  281. Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

  282. University of Groningen, University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands

  283. Department of Genetics, University Medical Center Groningen, Groningen, The Netherlands

  284. Department of Psychiatry, University Medical Center Groningen, Groningen, The Netherlands

  285. Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA

  286. Programs in Metabolism and Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA

  287. Diabetes Unit and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA. Harvard Medical School, Boston, Massachusetts, USA

  288. Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital, Boston, MA, USA

  289. Brigham and Women’s Hospital, Boston, MA, USA

  290. Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA

  291. Department of Neurology, Massachusetts General Hospital, Boston, MA, USA

  292. Division of General Internal Medicine, Massachusetts General Hospital and Dpeartment of Medicine, Harvard Medical School and Program in Medical and Population Genetics, Broad Institute, Boston, MA, USA

  293. Division of Genetics, Department of Medicine, Brigham and Women’s Hospital, Broad Institute of MIT and Harvard, Harvard Medical School, Boston, MA, USA

  294. Division of Genetics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA, USA

  295. Seaver Autism Center for Research and Treatment

  296. Department of Psychiatry

  297. Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA

  298. Mount Sinai Clinical Intelligence Center, Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA

  299. Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA

  300. Sema4, a Mount Sinai venture, Stamford CT, 06902, USA

  301. Seaver Autism Center for Research and Treatment, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA

  302. Mount Sinai Clnical Intelligence Center, Charles Bronfman Institute for Personalized Medicine

  303. Department of Genetics & Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA

  304. Mount Sinai Clinical Intelligence Center, Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA

  305. Icahn Institute of Data Science and Genomics Technology, New York, NY 10029, USA

  306. Mount Sinai Clinical Intelligence Center, New York, NY 10029, USA

  307. Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA

  308. Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA

  309. Institute for Genomic Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA

  310. The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA

  311. The Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA

  312. Pamela Sklar Division of Psychiatric Genomics, Department of Psychiatry, Department of Genetic and Genomic Sciences

  313. Pamela Sklar Division of Psychiatric Genomics, Department of Psychiatry, Department of Genetic and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA

  314. Seaver Autism Center for Research and Treatment, Department of Psychiatry

  315. Mount Sinai Clinical Intelligence Center, Department of Psychiatry, Department of Genetic and Genomic Sciences, Icahn School of Medicine at Mount Sinai, NY, 10029, USA

  316. Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA

  317. Mount Sinai Clinical Intelligence Center

  318. The Hasso Plattner Institute of Digital Health at Mount Sinai

  319. BioMe Phenomics Center, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA

  320. Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA

  321. Pamela Sklar Division of Psychiatric Genomics, Seaver Autism Center for Research and Treatment, Department of Psychiatry, Department of Genetic and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA

  322. Regeneron Genetics Center, Tarrytown, NY, USA

  323. Phenomic Analytics & Clinical Data Core, Geisinger Health System, Danville, PA, USA

  324. Department of Population Health Sciences, Geisinger Health System, Danville, PA, USA

  325. Department of Molecular and Functional Genomics, Geisinger Health System, Danville, PA, USA

  326. Vrije Universiteit Amsterdam, Amsterdam, UK

  327. Department of Genetics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA

  328. Department of Biomedical Data Science, Stanford University, Stanford, CA, USA

  329. Genomics Research Department, Saudi Human Genome Project, King Fahad Medical City and King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia

  330. Developmental Medicine Department, King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard-Health Affairs, Riyadh, Kingdom of Saudi Arabia and Saudi Human Genome Project (SHGP), King Abdulaziz City for Science and Technology (KACST), Satellite Lab at King Abdulaziz Medical City (KAMC), Ministry of National Guard Health Affairs (MNG-HA), Riyadh, Kingdom of Saudi Arabia.

  331. College of Applied Medical Sciences, Taibah University, Madina, Saudi Arabia

  332. Developmental Medicine Department, King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia

  333. Life Science and environmental institute, King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia

  334. The Liver Transplant Unit, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. The Division of Gastroenterology and Hepatology, Johns Hopkins University

  335. Department of Pathology, College of Medicine, King Saud University, Riyadh, Saudi Arabia

  336. Titus Family Department of Clinical Pharmacy, USC School of Pharmacy University of Southern California

  337. KACST-BWH Centre of Excellence for Biomedicine, Joint Centers of Excellence Program, King Abdulaziz City for Science and Technology (KACST), Riyadh, Kingdom of Saudi Arabia

  338. Ministry of the National Guard Health Affairs, King Abdullah International Medical Research Center and King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Kingdom of Saudi Arabia

  339. Ohud Hospital, Ministry of Health, Madinah,Saudi Arabia

  340. Pediatric Infectious Diseases, Children’s Specialized Hospital, King Fahad Medical City, Riyadh, Saudi Arabia

  341. The Saudi Biobank, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia

  342. Developmental Medicine Department, King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sciences, King AbdulAziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Kingdom of Saudi Arabia

  343. Department of Pathology and Laboratory Medicine, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences and King Abdullah International Medical Research Center, Riyadh, Saudi Arabia

  344. Laboratory Department, Security Forces Hospital, General Directorate of Medical Services, Ministry of Interior

  345. King Abdulaziz City for Science and Technology (KACST), Riyadh, Kingdom of Saudi Arabia

  346. Department of Developmental Medicine, King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia

  347. Titus Family Department of Clinical Pharmacy, USC School of Pharmacy

  348. Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia.

  349. Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden

  350. Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany

  351. Stanley Center for Psychiatric Research & Program in Medical and Population Genetics

  352. Anaesthesiology and Intensive Care Medicine, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden

  353. Integrative Physiology, Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden

  354. Hedenstierna Laboratory, CIRRUS, Anaesthesiology and Intensive Care Medicine, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden

  355. Division Anesthesiology and Intensive Care, CLINTEC, Karolinska Institutet, Stockholm, Sweden

  356. Department of Genetics and Bioinformatics, Norwegian Institute of Public Health, Oslo, Norway.

  357. Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway.

  358. Department of Method Development and Analytics, Norwegian Institute of Public Health, Oslo, Norway.

  359. King’s College London, Department of Twin Research and Genetic Epidemiology, London, UK

  360. NIHR Biomedical Research Centre at Guy’s and St Thomas’ Foundation Trust, London, UK

  361. Genomics England

  362. Queen Mary University, London, United Kingdom

  363. William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK

  364. UCL Great Ormond Street Institute of Child Health, London, United Kingdom

  365. Genomics England, London, United Kingdom

  366. University of Cambridge, London, United Kingdom

  367. Department of Human Genetics, McGill University, Montréal, Québec, Canada. Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada. Kyoto-McGill International Collaborative School in Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Research Fellow, Japan Society for the Promotion of Science

  368. Big Data Institute, Nuffield Department of Population Health, University of Oxford, Li Ka Shing Centre for Health Information and Discovery, Old Road Campus, Oxford, OX3 7LF, United Kingdom

  369. Genomics PLC, King Charles House, Park End Street, Oxford, OX1 1JD, United Kingdom

  370. Nuffield Department of Medicine, Experimental Medicine Division, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom

  371. Public Health England, Field Service, Addenbrooke’s Hospital, Cambridge, CB2 0QQ, United Kingdom

  372. Public Health England, Data and Analytical Services, National Infection Service, London, NW9 5EQ, United Kingdom

  373. Program in Bioinformatics and Integrative Genomics, Harvard Medical School, Boston, MA, USA

  374. Program in Biological and Biomedical Sciences, Harvard Medical School, Boston, MA, USA

  375. Wellcome Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, United Kingdom

  376. Department of Clinical Research and Leadership, George Washington University, Washington, DC, USA

  377. Department of Human Genetics, The Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1HH, UK

  378. The National Institute for Health Research Blood and Transplant Unit in Donor Health and Genomics, University of Cambridge, Strangeways Research Laboratory, Wort’s Causeway, Cambridge, CB1 8RN, UK

  379. Department of Haematology, University of Cambridge, Cambridge Biomedical Campus, Long Road, Cambridge, CB2 0PT, UK

  380. British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK

  381. British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge, UK

  382. National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics, University of Cambridge, Cambridge, UK

  383. Health Data Research UK Cambridge, Wellcome Genome Campus and University of Cambridge, Cambridge, UK

  384. Department of Human Genetics, Wellcome Sanger Institute, Hinxton, UK

  385. Department of Epidemiology, Emory University Rollins School of Public Health

  386. Atlanta CA Health Care System, North Druid Hills, GA, USA

  387. Center for Population Genomics, MAVERIC, VA Boston Healthcare System, Boston, MA, USA

  388. MAVERIC, VA Boston Healthcare System, Boston, MA, USA

  389. Stanford University

  390. Palo Alto VA Healthcare System, Stanford, CA, USA

  391. Department of Biostatistics, Boston Univeristy School of Public Health

  392. Vanda Pharmaceuticals Inc.

  393. Stroke Pharmacogenomics and Genetics, Biomedical Research Institute Sant Pau, Sant Pau Hospital, Barcelona, Spain

  394. Institute for Biomedical Researhc of Barcelona (IIBB), National Spanish Research Council (CSIC)

  395. Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain

  396. Institute of Biomedicine of Valencia (IBV), CSIC, València, Spain

  397. Network Center for Biomedical Research on Neurodegenerative Diseases (CIBERNED), València, Spain

  398. Neurology and Genetic Mixed Unit, La Fe Helath Research Institute, València, Spain

  399. Institute for Biomedical Research of Barcelona (IIBB), National Spanish Research Council (CSIC)

  400. Department of Neurology, Hospital Universitari MútuaTerrassa, Fundació Docència i Recerca MútuaTerrassa, Terrassa, Spain

  401. Department of Molecular and Cell Biology, Centro Nacional de Biotecnología (CNB-CSIC), Campus Universidad Autónoma de Madrid, 28049 Madrid, Spain

  402. Instituto de Física de Cantabria (IFCA-CSIC)

  403. Hospital Clínic, IDIBAPS, Barcelona, Spain

  404. Hospital Clínic, Barcelona, Spain

  405. Hospital Clínic, IDIBAPS, School of Medicine, University of Barcelona Barcelona, Spain

  406. IDIBAPS, Barcelona, Spain

  407. IIBB-CSIC, Barcelona, Spain

  408. Servicio de Salud del Principado de Asturias, Oviedo, Spain

  409. Hospital Mutua de Terrassa, Terrassa, Spain

  410. Hospital Valle Hebrón, Barcelona, Spain

  411. Instituto de Biomedicina y Genética Molecular (IBGM), CSIC-Universidad de Valladolid, Spain

  412. Hospital Clínico Universitario de Valladolid (SACYL)

  413. Department of Neurology, University Hospital of Albacete.

  414. Department of Neurology

  415. Research Unit, University Hospital of Albacete

  416. Department of Neurology, Biomedical Research Institute Sant Pau (IIB Sant Pau), Hospital de la Santa Creu i Sant Pau, Barcelona (Spain)

  417. Hospital Universitario Ramón Y Cajal, IRYCIS, Madrid, Spain

  418. Institute de Biomedicine of Seville, IBiS/Hospital Universitario Virgen del Rocío/CSIC/University of Seville & Department of Neurology, Hospital Universitario Virgen Macarena, Seville.

  419. Brigham and Women’s Hospital, Boston, USA

  420. Harvard Medical School, Boston, MA

Footnotes

  • Figure 2 revised; Added analysis; Supplemental files updated.

References

  1. 1.↵
    COVID-19 Host Genetics Initiative. Mapping the human genetic architecture of COVID-19. Nature (2021). doi:10.1038/s41586-021-03767-x
    OpenUrlCrossRef
  2. 2.↵
    Hobbs, B. D. et al. Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis. Nat. Genet. 49, 426–432 (2017).
    OpenUrlCrossRefPubMed
  3. 3.↵
    Shrine, N. et al. New genetic signals for lung function highlight pathways and chronic obstructive pulmonary disease associations across multiple ancestries. Nat. Genet. 51, 481–493 (2019).
    OpenUrlCrossRefPubMed
  4. 4.↵
    Hsieh, M.-H. et al. Human Surfactant Protein D Binds Spike Protein and Acts as an Entry Inhibitor of SARS-CoV-2 Pseudotyped Viral Particles. Front. Immunol. 12, 641360 (2021).
    OpenUrl
  5. 5.↵
    Hediger, M. A. et al. The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteinsIntroduction. Pflugers Arch. 447, 465–468 (2004).
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    Deelen, P. et al. Improving the diagnostic yield of exome-sequencing by predicting gene-phenotype associations using large-scale gene expression analysis. Nat. Commun. 10, 2837 (2019).
    OpenUrlCrossRefPubMed
  7. 7.↵
    Seibold, M. A. et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. N. Engl. J. Med. 364, 1503–1512 (2011).
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    Fadista, J. et al. Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity. EBioMedicine 65, 103277 (2021).
    OpenUrl
  9. 9.↵
    Peljto, A. L. et al. Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis. JAMA 309, 2232–2239 (2013).
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    Vuille-Dit-Bille, R. N. et al. Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors. Amino Acids 47, 693–705 (2014).
    OpenUrl
  11. 11.↵
    Horowitz, J. E. et al. Common genetic variants identify targets for COVID-19 and individuals at high risk of severe disease. medRxiv (2021). doi:10.1101/2020.12.14.20248176
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    Wright, J. R. Immunoregulatory functions of surfactant proteins. Nat. Rev. Immunol. 5, 58–68 (2005).
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    Roy, M. G. et al. Muc5b is required for airway defence. Nature 505, 412–416 (2014).
    OpenUrlCrossRefPubMedWeb of Science
Back to top
Posted February 09, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Mapping the human genetic architecture of COVID-19: an update
COVID-19 Host Genetics Initiative, Andrea Ganna
medRxiv 2021.11.08.21265944; doi: https://doi.org/10.1101/2021.11.08.21265944
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area